Despite its broad expression, heterozygous loss of CHD7 in humans leads to CHARGE syndrome, a tissue-specific neurocristopathy affecting structures patterned by, or derived from, neural crest cells. The gene discussed is CHD7; the disease is CHARGE syndrome.